SHAFTESBURY MEDICAL CTR. — All Prescriptions & Medications — Page 5
Practice Code: B86016 | LEEDS, LS9 9EF
Showing results 201-250 of 773
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Nebivolol | 303 | 8,421 | £2.6K | +185.8% ▲ |
| 296 | 41.0K | £1.9K | +324.2% ▲ | |
| Estriol | 294 | 4,619 | £3.5K | +38.2% ▲ |
| Nicorandil | 291 | 12.9K | £1.8K | +102.1% ▲ |
| Ivabradine | 291 | 8,176 | £1.5K | +206.1% ▲ |
| Methenamine hippurate | 290 | 11.9K | £2.8K | +218.8% ▲ |
| Carvedilol | 287 | 9,758 | £389 | +152.9% ▲ |
| Metoclopramide hydrochloride | 287 | 16.2K | £861 | +246.4% ▲ |
| Peppermint oil | 270 | 23.2K | £3.1K | +239.3% ▲ |
| Nizatidine | 269 | 5,700 | £5.9K | +681.9% ▲ |
| Brinzolamide | 268 | 2,360 | £1.9K | +106.3% ▲ |
| Meloxicam | 255 | 6,571 | £193 | +285.5% ▲ |
| Coal tar | 255 | 72.9K | £1.9K | +250.3% ▲ |
| Ondansetron hydrochloride | 254 | 12.8K | £6.3K | +423.4% ▲ |
| Powder 1.6 kcal/ml milkshake (0913011) | 254 | 378.2K | £6.3K | +240.7% ▲ |
| RtS 2-2.4 kcal/ml m/sk higher protein,higher energy(0913011) | 253 | 2.1M | £24.8K | +478.3% ▲ |
| Ranolazine | 251 | 6,668 | £1.2K | +47.7% ▲ |
| Fusidic acid | 248 | 4,080 | £545 | +94.2% ▲ |
| Pizotifen malate | 246 | 11.1K | £491 | +198.5% ▲ |
| Urea | 243 | 106.1K | £4.2K | +263.7% ▲ |
| 241 | 28.5K | £1.2K | +83.9% ▲ | |
| Tadalafil | 238 | 4,686 | £3.0K | +40.0% ▲ |
| Hydrocortisone | 236 | 6,830 | £1.7K | +179.5% ▲ |
| Benzydamine hydrochloride | 236 | 20.5K | £533 | +205.1% ▲ |
| Carbomer 940/980 | 231 | 3,530 | £752 | +51.7% ▲ |
| Co-amilofruse (Amiloride hydrochloride/frusemide) | 227 | 4,263 | £609 | +552.5% ▲ |
| Cefalexin | 227 | 8,532 | £594 | +95.2% ▲ |
| Carbimazole | 227 | 6,891 | £752 | +101.0% ▲ |
| Hydroxyzine hydrochloride | 225 | 6,076 | £186 | +322.4% ▲ |
| RtS 2.4 kcal/ml m/sk lower volume, higher protein (0913011) | 223 | 1.2M | £24.6K | +218.7% ▲ |
| Bisacodyl | 221 | 11.8K | £720 | +68.6% ▲ |
| Co-amoxiclav (Amoxicillin/clavulanic acid) | 220 | 8,871 | £720 | +44.0% ▲ |
| Hydrocortisone | 219 | 6,111 | £1.6K | +188.3% ▲ |
| Alfuzosin hydrochloride | 218 | 6,304 | £1.8K | +204.8% ▲ |
| Nefopam hydrochloride | 216 | 18.1K | £795 | +91.0% ▲ |
| Haloperidol | 214 | 5,005 | £13.2K | +349.3% ▲ |
| Fentanyl | 214 | 1,706 | £4.5K | +108.9% ▲ |
| 214 | 32.6K | £4.6K | +449.7% ▲ | |
| Azithromycin | 210 | 2,422 | £758 | +65.7% ▲ |
| Biphasic isophane insulin | 208 | 1,668 | £7.2K | +86.4% ▲ |
| Lorazepam | 206 | 4,849 | £1.1K | +44.5% ▲ |
| Nystatin | 205 | 6,720 | £386 | +103.4% ▲ |
| Ascorbic acid | 205 | 3,668 | £4.6K | +898.4% ▲ |
| Fluticasone propionate (Nasal) | 205 | 691 | £2.7K | +40.8% ▲ |
| 204 | 97.4K | £942 | +123.7% ▲ | |
| Triamcinolone acetonide | 196 | 307 | £430 | +162.0% ▲ |
| 194 | 22.8K | £1.1K | -29.8% ▼ | |
| Telmisartan | 193 | 4,501 | £1.1K | +232.9% ▲ |
| Etoricoxib | 193 | 7,808 | £1.8K | +139.5% ▲ |
| Valproic acid | 192 | 7,110 | £2.0K | +120.7% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.